BYFAVO: payments to doctors
Payments that named BYFAVO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $904K
- Providers
- 5,379
- Transactions
- 8,532
- Average per transaction
- $106
The per-transaction average — $106 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,379 providers the average total is $168, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acacia Pharma Inc | $643,537 | 71.2% |
| Eagle Pharmaceuticals, Inc. | $251,112 | 27.8% |
| Mylan Inc. | $9,586 | 1.1% |